Hi Guest
X   

Real-Time Quote

Enter Company or MF
   

Glenmark Pharmaceuticals Ltd.

532296  GLENMARK  Group (A) BSE data View Tips   Add to :  Portfolio  |  Watchlist  |  Game

How hot is this stock?  © Rediff.com

60
Price*         
Volume*         
MF holdings         
Sales         
Net profit margin         
  * Computed on last 15 days' trading figures.
Type Numbers Only
Advanced

If you had invested…

Rs ago
You would have
Rs 00,00,00,000.00

* Based on prev close (src - Rediff MoneyWiz)

Report card

AttributeValueDate
PE ratio 29.2120/11/09
EPS (Rs) 8.70Mar, 09
Sales (Rs crore) 236.10Sep, 09
Face Value (Rs)1 
Net profit margin (%) 24.03Mar, 09
Last bonus1:106/01/05
Last dividend (%)4029/06/09
Return on average equity17.71Mar, 09

Research centre

Results
Quarterly - Half yearly - Annual
Statement
Balance sheet - P&L - Cash flow
More
Dividend - Bonus - Share holding
Capital structures - Ratio

MFs invested in this company 

Scheme% of asset size
SBI Magnum Sector Funds Umbrella - Pharma - Growth5.92 
SBI Magnum Sector Funds Umbrella - Pharma - Dividend5.92 
Kotak Emerging Equity Scheme - Growth3.33 
Kotak Emerging Equity Scheme - Dividend3.33 
IDFC Small and Midcap Equity Fund - Growth2.84 

Announcements

19/11/09
Glenmark Pharmaceuticals - Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
16/11/09
Glenmark Pharmaceuticals outlicenses a specialty pharmaceutical product to Medicis Pharmaceutical for the North America Regio
14/11/09
Glenmark Pharmaceuticals - Glenmark Generics receives ANDA approval from US-FDA for Ciclopirox Olamine Cream
29/10/09
Board Meeting
29/10/09
Glenmark Pharmaceuticals - Outcome of Board Meeting
29/10/09
Glenmark Pharmaceuticals - Updates

Compare with

CompanyPrev close
417.30
1,414.95
531.95
263.10
572.00
304.55
560.45
1,101.05
106.10
1,702.30